Final Program

Friday, March 20

09:00 – 12:00:

Physiotherapist and Investigator Training Workshop
Core dataset – adults (DM1 and DM2) and pediatrics (Kate Eichinger)

Topics:

  • 10-Meter Walk/Run Test (10MWRT)
  • Manual Muscle Testing (11 muscle pairs)
  • Muscular Impairment Rating Scale (MIRS)
  • Handgrip strength (JAMAR dynamometer)
  • Sit-to-Stand Test (5 repetitions)
  • HOT (Hands-on Training)
  • North Star Ambulatory Assessment (NSAA)

13:00 – 14:00:

Lunch buffet

14:00 – 16:00:

Cognitive Training Workshop
Core dataset – adults and pediatrics

17:00 – 17:15:

Opening Session
(Valeria Sansone, Guillaume Bassez, Benedikt Schoser)

17:15 – 17:45:

Define the Meeting Objectives – Start-up Activities – Part I

  • Structure of the EU-CRTN (Valeria Sansone, Nicholas E. Johnson)
  • On-going active projects and activities (Guillaume Bassez, Benedikt Schoser)

 

17:45 – 19.40:

Scientific talks: Translational and Clinical Insights in Myotonic Dystrophy

Moderator: Chris Turner, Stefan Winblad

  • 17.45-18.05:  CNS: Preclinical data clinical correlates (Mario Gomes Pereira)
  • 18.05-18.25:  Muscle MRI (Matteo Garibaldi)
  • 18.25-18.45:  Brain MRI (Gabriele Siciliano)
  • 18.45-19.05:  Pediatric CNS workshop results (Valeria Sansone)
  • 19.05-19.25:  Pediatric GI workshop results – (Hilde Braakman)
  • 19.25-19.40:  Discussion – All

20:30:

Networking dinner

Saturday, March 21

08:30 – 10.00:

Start-up Activities – Part II
(Valeria Sansone, Benedikt Schoser)

  • Data governance, sharing & GDPR (Valeria Sansone)
  • Registries & EMA requirements (Benedikt Schoser)
  • Data access & project implementation (Nicholas E. Johnson)
  • SOPs & Specific tools (Guillaume Bassez) 

10.00 – 11.15:

Scientific talks: Registry Updates and Clinical Research Developments in Myotonic Dystrophies:

Moderators: Peter Bram ‘t Hoen, Roberto Massa

  • 10.00-10.20:  END-DM1 & Extension (Nicholas E. Johnson)
  • 10.20-10.40:  DM2 update and End-DM2 (Benedikt Schoser)
  • 10.40-11.00:  Registry alignment (Guillaume Bassez)
  • 11.00-11.15:   Discussion – All

11.15 – 11.30:

Coffee Break

11.30-13.10:

Scientific talks: Global Insights and Collaborative Advances in DM

Moderators: Nicholas E. Johnson, Gabriella Silvestri

  • 11:30–11:50 – Splicing update (Melissa Hale)
  • 11:50–12:10 – Japanese Network – fostering integration (Masanori Takahashi)
  • 12:10–12:30 – DM1-Hub Project (Spain) (Gisela Nogales Gadea)
  • 12:30–12:50 – Drug Development Update: New Treatments (Karlien Mul)
  • 12:50–13:00 – Discussion

13.00-14.00

Working Lunch

14.00-16.00

Stakeholders Perspective Session – Bridging the Gap for Clinical Site Preparedness

Moderators: Benedikt Schoser, Guillaume Bassez

14:00 – 14:30 – Patients’ Organization: What is the role of the patients? (Andy Rohwasser, Baas Haasakker, Jorg van Gent)

14:30 – 15:00 – Site Readiness: Clinician Perspective (Valeria Sansone)

15:00 – 16:00 – Round table: Ask the Industry – Gaining Insights and Perspectives (Allison Kreuzer, Fares Nigim, Johan van Beek, Julia Presanis, Alla Zozulya Weidenfeller)

16:00 – 17:00:

Wrap-up & Next Steps & Meeting (Scientific Committee)